Skip to content

Clinical trials

Phase 3 Hematologic Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Phase: Phase 3 Country / region: France Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20122
20132
20145
20151
20172
20182
20192
20201
20217
20223
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting10
Terminated4
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Loxo Oncology, Inc.5
Pfizer5
Novartis Pharmaceuticals3
AOP Orphan Pharmaceuticals AG2
CTI BioPharma2
Genzyme, a Sanofi Company2
Seagen Inc.2
Agios Pharmaceuticals, Inc.1
Amgen1
Ariad Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases31
Bone Marrow Diseases10
Myeloproliferative Disorders8
Anemia6
Hemorrhagic Disorders6
Lymphoma, Non-Hodgkin6
Polycythemia Vera6
Lymphoma, B-Cell5
Anemia, Sickle Cell4
Genetic Diseases, Inborn4

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.